For instance, our analysis identified promoter hypermethylation and underexpression of ligand CXCL12 in six cancer types, and previous studies have reported epigenetically induced silencing of this gene in breast cancer (64), colon cancer (65) and non-small cell lung cancers (66). Here, CXCL12 is linked to colonic neoplasm.